Identification of novel 3-aryl-1-aminoisoquinolines-based KRASG12C inhibitors: Rational drug design and expedient construction

C[sbnd]H functionalizationannulation

★ 5.0 · 11 reads

Sign in to save this
Request Code
ZLIB.IO18509660
Published
2022
Pages
1
Language
Unknown